Eli Rosenbaum
- Cancer Research top 2%
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 14
-
- Prostate Cancer Treatment and Research 37
- Prostate Cancer Diagnosis and Treatment 15
- Renal cell carcinoma treatment 14
- Otorhinolaryngology top 5%
-
- Bladder and Urothelial Cancer Treatments 17
-
- Radiopharmaceutical Chemistry and Applications 15
-
- Epigenetics and DNA Methylation 12
-
- Economic and Financial Impacts of Cancer 9
- Co-authors
- David SidranskyWilliam H. WestraMohammad Obaidul HoqueYoram CohenShahnaz BegumMarianna ZahurakRui HenriqueRalph P. Tufano
- Journals
- Journal of Clinical Oncology (35 papers)Annals of Oncology (7 papers)Clinical Cancer Research (6 papers)
- Partner nations
- IsraelUnited StatesItaly
In The Last Decade
Eli Rosenbaum
106 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 116
- Endocrinology, Diabetes and Metabolism 787
- Cancer Research 655
- Oncology 1.0k
- Pulmonary and Respiratory Medicine 972
- Otorhinolaryngology 128
Countries citing papers authored by Eli Rosenbaum
This map shows the geographic impact of Eli Rosenbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Rosenbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Rosenbaum more than expected).
Fields of papers citing papers by Eli Rosenbaum
This network shows the impact of papers produced by Eli Rosenbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Rosenbaum. The network helps show where Eli Rosenbaum may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eli Rosenbaum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 6 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 2 | |
| 7 | 2021 | 5 | |
| 8 | 2019 | 1 | |
| 9 | 2017 | 21 | |
| 10 | 2017 | 58 | |
| 11 | 2016 | 0 | |
| 12 | 2016 | 1 | |
| 13 | 2012 | 2 | |
| 14 | 2011 | 34 | |
| 15 | 2011 | 48 | |
| 16 | 2008 | 115 | |
| 17 | 2006 | 157 | |
| 18 | 2006 | 212 | |
| 19 | 2005 | 104 | |
| 20 | 2004 | 135 |
About Eli Rosenbaum
Eli Rosenbaum is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Radiology, Nuclear Medicine and Imaging and Otorhinolaryngology, having authored 112 papers that have together received 3.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (37 papers), Bladder and Urothelial Cancer Treatments (17 papers), Radiopharmaceutical Chemistry and Applications (15 papers), Prostate Cancer Diagnosis and Treatment (15 papers), Renal cell carcinoma treatment (14 papers), Cancer Immunotherapy and Biomarkers (14 papers), Epigenetics and DNA Methylation (12 papers) and Economic and Financial Impacts of Cancer (9 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (787 citations), Cancer Research (655 citations), Oncology (1.0k citations), Pulmonary and Respiratory Medicine (972 citations) and Otorhinolaryngology (128 citations). Eli Rosenbaum has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include David Sidransky, William H. Westra, Mohammad Obaidul Hoque, Yoram Cohen, Shahnaz Begum, Marianna Zahurak, Rui Henrique, Ralph P. Tufano, Wim Van Criekinge and Martha A. Zeiger. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, The Journal of Urology and Clinical Genitourinary Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.